Abcam plc (ABC) Ord 0.2p
Share news, reports & tips
11 November 2019 10:45
(Sharecast News) - Research tools supplier Abcam has agreed to buy Expedeon's proteomics and immunology businesses for €120m.
16 September 2019 12:59
(Sharecast News) - Schroders: Jefferies downgrades to hold with a target price of 3,100p.
22 July 2019 13:27
(Sharecast News) - Asos: JP Morgan downgrades to neutral with a target price of 3,800p.
22 July 2019 09:01
(Sharecast News) - Research tools supplier Abcam reported an improvement in full-year revenues on Monday but its shares came under pressure amid concerns about the company' growth plans and news that...
16 July 2019 12:30
(Sharecast News) - Abcam has acquired the live cell line and lysates portfolio of EdiGene Inc, a company focused on using genome editing technology to create novel therapeutics for a range of diseases.
27 June 2019 11:16
(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.
25 March 2019 08:26
(Sharecast News) - Wood Group: Jefferies downgrades to underperform with a target price of 480p.
4 March 2019 11:50
(Sharecast News) - Abcam's shares dropped sharply on Monday after stating its outlook will be impacted by "continued softness" in Japan, though the company reported growth for interim revenue...
28 January 2019 08:35
(Sharecast News) - Antibody supplier Abcam has acquired Californian monoclonal antibodies manufacturer Calico Biolabs for an undisclosed amount.
9 January 2019 12:26
(Sharecast News) - Nichols: Numis upgrades to add with a target price of 1,650p.
8 January 2019 08:17
(Sharecast News) - Abcam reported on Tuesday that it remains on track to meet full-year financial targets due to double digit revenue growth following the company's expansion in China.
10 September 2018 08:28
(Sharecast News) - Life sciences research firm Abcam saw its shares dive on Monday after a strong set of preliminary results were overshadowed by the firm's profit forecast for the new financial year...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.